Challenges Abound As India Seeks To Raise Immunization Rate
This article was originally published in PharmAsia News
Executive Summary
India's health minister has announced an ambitious target of ensuring a full child immunization rate of 95% in the next 18 months, up from an overall rate of 65% now, and has appealed to the private sector to help achieve the goal.
You may also be interested in...
IIL's Combo Vaccine Wins Big Indian Tender, But Pentavalent Concerns Linger
State-owned Indian Immunologicals Ltd., one of the local companies aiming to challenge the dominance of multinationals in the domestic Indian vaccine market, has come up with a low-priced five-in-one jab for children that the government is including in its massive national immunization program.
Share Fillip As Indian Pharma Crests US Regulatory Hump
For the last few years, Indian generic companies have been making headlines for all the wrong reasons, rapped by the US Food and Drug Administration over problems ranging from fudged test results to poor-quality manufacturing standards. But lately, the firms have been enjoying a run of good regulatory tidings, giving a fillip to their share prices.
Biocon, Quark Win Pioneering Indian Nod For RNAi Eye Therapy Trial
Asia’s biggest biotech company, India’s Biocon Ltd, has announced it will conduct what it says is the first-ever clinical trial of a siRNA therapy in India with US partner Quark, is aimed at tackling a rare eye condition.